Testosterone and the prostate: Risk-benefits of testosterone therapy in hypogonadal men

Description

Dr. Abraham Morgentaler talks about the paradigm shift regarding testosterone and prostate cancer. He highlights that there is no evidence that high testosterone causes prostate cancer. He presents research showing that low testosterone is not protective, and contrary to common belief, low testosterone is associated with high-grade prostate cancer.


 

Speakers

Dr. Abraham Morgentaler

Abraham Morgentaler, MD, FACS
Founder, Men's Health Boston
Associate Clinical Professor of Urology
Harvard Medical School
Boston, Massachusetts, USA